This brand name is authorized in Nigeria.
The drug CLAVOPIL contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
804826J2HU - AMOXICILLIN
|
|
Amoxicillin is a semisynthetic penicillin (beta-lactam antibiotic) that inhibits one or more enzymes (often referred to as penicillin-binding proteins, PBPs) in the biosynthetic pathway of bactericidal peptidoglycan, which is an integral structural component of the bacterial cell wall. Inhibition of peptidoglycan synthesis leads to weakening of the cell wall, which is usually followed by cell lysis and death. |
|
2
|
UNII
Q42OMW3AT8 - CLAVULANATE POTASSIUM
|
|
Clavulanic acid is a beta-lactam structurally related to penicillins. It inactivates some beta-lactamase enzymes thereby preventing inactivation of amoxicillin. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| C4-1501 | Tablet | Clavopil 625 Tablets TAB 500 mg; 125 mg 2 x 7's (in Alu-Alu blisters) | Film-coated tablet. White coloured, elongated shaped, biconvex, film-coated tablet having plain surface on both sides | 21/12/2020 |
| C4-1599 | Tablet | Clavopil 1000 Tablets TAB 875 mg; 125 mg 2 x 7's (in Alu-Alu blisters) | White coloured, caplet shaped, biconvex, film-coated tablet having plain surface on both sides | 25/02/2021 |
| C4-1600 | Powder for suspension | Clavopil Powder for Oral Suspension PWD_F_SOL 200 mg/5 mL; 28.5 mg/5 mL 1 x 70 mL (in HDPE plastic bottle) | Powder For Oral Suspension (Dry Syrup). A white to creamish granular powder filled in 70-mL HDPE plastic bottle, after reconstitution with water it gives creamish colored homogenous suspension with strawberry flavour | 25/02/2021 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| J01CR02 | Amoxicillin and enzyme inhibitor | J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01C Beta-lactam antibacterials, penicillins → J01CR Combinations of penicillins, incl. beta-lactamase inhibitors |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | C4-1501, C4-1599, C4-1600 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.